Clinical Trial Update: All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II trial investigating the combination of all-trans retinoic acid with toripalimab and chemotherapy for locally advanced inoperable or metastatic triple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Triple Negative Breast Cancer (TNBC) | Phase 2 | Status: RECRUITING